← Back to Clinical Trials
Recruiting NCT07238205

NCT07238205 Mixed Reality Training for Teaching Cervical Effacement and Dilation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07238205
Status Recruiting
Phase —
Sponsor Mardin Artuklu University
Condition Labor; Poor, Primary
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2025-10-01
Primary Completion 2025-12-01

Eligibility & Interventions

Sex Female only
Min Age 18 Months
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
mixed reality educationStandard Education Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2025-10-01 with a primary completion date of 2025-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this educational research is to determine whether a mixed reality-based training program is effective in teaching midwifery students how to assess cervical effacement and dilation. The study also examines the impact of mixed reality on students' cognitive load, sense of presence, and midwifery professional perception. The main questions the study seeks to answer are: Does mixed reality training reduce students' cognitive load? Does mixed reality increase the students' sense of presence? How does mixed reality-based training influence students' professional perception of midwifery? Do students who receive mixed reality training perform better in assessing cervical effacement and dilation on real pregnant women compared with the control group?

Eligibility Criteria

Inclusion Criteria: * Enrolled in the Midwifery Department at Mardin Artuklu University, * Taking the course "Normal Birth and Postpartum Care," * Who have not previously received any structured training (practical training, simulation, etc.) related to vaginal examination or cervical dilation/effacement procedures, * Who do not feel confident in assessing cervical effacement and dilation, * Who volunteer to participate in the study will be included, * Pregnant women who are in the first stage of labor and have no obstetric complications. Exclusion Criteria: * Individuals who are graduates of health vocational high schools, * Have disabilities in their eyes, hands, arms, or fingers, * Those who do not complete the training will not be included.

Contact & Investigator

Central Contact

Ülkin Gündüz Aruser, Ph.D

✉ ulkingunduz@artuklu.edu.tr

📞 +905314592113

Principal Investigator

Ülkin Gündüz Aruser, Ph.D

PRINCIPAL INVESTIGATOR

Mardin Artuklu University

Frequently Asked Questions

Who can join the NCT07238205 clinical trial?

This trial is open to female participants only, aged 18 Months or older, up to 35 Years, studying Labor; Poor, Primary. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07238205 currently recruiting?

Yes, NCT07238205 is actively recruiting participants. Contact the research team at ulkingunduz@artuklu.edu.tr for enrollment information.

Where is the NCT07238205 trial being conducted?

This trial is being conducted at Mardin, Turkey (Türkiye).

Who is sponsoring the NCT07238205 clinical trial?

NCT07238205 is sponsored by Mardin Artuklu University. The principal investigator is Ülkin Gündüz Aruser, Ph.D at Mardin Artuklu University. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology